Paclitaxel loaded carrier based biodegradable polymeric implants: Preparation and in vitro characterization

Saudi Pharmaceutical Journal

Volumn 21, Issue 1, 2013, Pages 85-91

  Hiremath, Jagadeesh G ^a   Khamar, Nirav S ^a   Palavalli, Subhash G ^a   Rudani, Chetan G ^a   Aitha, Rajeshkumar ^a   Mura, Prasanthkumar ^a  

^a East West College of Pharmacy   (India)

Author keywords

Cyclodextrin; Implants; Paclitaxel (PTX); Poly( caprolactone)

Indexed keywords

BETA CYCLODEXTRIN; EXCIPIENT; MACROGOL; PACLITAXEL; PHOSPHATE BUFFERED SALINE; POLYCAPROLACTONE;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG IMPLANT; IN VITRO STUDY; INFRARED SPECTROSCOPY; PH; SCANNING ELECTRON MICROSCOPY; THICKNESS; WEIGHT;

EID: 84872002753     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2011.12.002     Document Type: Article

References (15)

1. Anand B.D., Ramesh P. Development and characterization of biodegradable chitosan films for local delivery of paclitaxel. AAPS. J. 2004, 6(3):27.
2. Avgeropoulos N.C., Batchelor T.T. New treatment strategies for malignant gliomas. Oncologist 1999, 4:209-224.
3. Costa P., Lobo J.M.S. Modelling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001, 13:123-133.
4. Dorr R.T. Pharmacology and toxicology of cremophor EL diluent. Ann. Pharmacother. 1994, 28:S11-S14.
5. Hiremath J.G., et al. Biodegradable Poly (sebacic acid-co-ricinoleic-ester anhydride) tamoxifen citrate implants: Preparation and in vitro characterization. J. Appl. Polymer. Sci. 2007, 107:2745-2754.
6. Horikoshi S., Sato H., Wang M.Y. In-vitro and in-vivo evaluation of taxol release from poly (lactic-co-glycolic acid) microspheres containing isopropyl myristate and degradation of the microspheres. J. Control. Release. 1997, 49:157-166.
7. Liu X., et al. Evaluation of two polymeric blends (EVA/PLA and EVA/PEG) as coating film materials for paclitaxel-eluting stent application. J. Mater. Sci. 2011, 22:327-337.
8. Ramesh D.V., et al. Microencapsulation of FITC-BSA into poly(e-caprolactone) by a water-in-oil-in-oil solvent evaporation technique. Trends Biomater. Artif. Organs. 2002, 15:31-36.
9. Rowinsky E.K., et al. Taxol: the first of the taxanes, an important new class of antitumor agents. Semin. Oncol. 1992, 1992(19):646-662.
10. Shikanov A., et al. Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel-effect of additives. J. Control. Release. 2005, 105:52-67.
11. Singla A.K., et al. Paclitaxel and its formulations. Int. J. Pharm. 2002, 235:179-192.
12. Sinha V.R., et al. Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int. J. Pharm. 2004, 278:1-23.
13. Spencer C.M., Faulds D. Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs 1994, 48:794-847.
14. Weiss R., et al. Hypersensitivity reactions from taxol. J. Clin. Oncol. 1990, 1990(8):1263-1268.
15. Zhang Y., et al. A novel paclitaxel-loaded poly(<epsilon> caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment. Acta. Biomed. 2010, 6:2045-2052.